Pfizer and Mylan Specialty, L.P. agreed to pay Massachusetts a total of $625,000 to settle allegations that a television advertisement for the EpiPen and EpiPen Jr. self-injectors was misleading and overstated the effectiveness of the product. The EpiPen device, which allows for self-injection of the steroid epinephrine for emergency treatment of allergic reactions, is made by Pfizer and marketed by Mylan. Massachusetts alleged that the television ad, which aired in April 2012, “put consumers at risk by giving an overall misleading impression that the product alone removes the need to take precautionary measures.” The television ad triggered a warning letter from the U.S. Food and Drug Administration in May 2012 and was pulled after parents and advocacy groups complained. Pfizer will pay Massachusetts $375,000. In December 2012, Pfizer paid Oregon $1 million over the same ad campaign (see Pfizer instance, “EpiPen Television Ad Settlement – Oregon”).